The Valley Desk

EditorialJournal of gastrointestinal oncologyPublished

Liposomal eribulin (E7389-LF) plus nivolumab: a potential treatment option for patients with advanced gastric cancer?

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Editorial
Venue
Journal of gastrointestinal oncology
Published
Subject terms
Immunotherapy; Gastric cancer; Chemotherapy; Nivolumab; Liposomal Eribulin
PubMed ID
39554561
PubMed Central ID
PMC11565124
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal